CS250227B2 - Testing system for substances' determination liquids - Google Patents

Testing system for substances' determination liquids Download PDF

Info

Publication number: CS250227B2
Authority: CS; Czechoslovakia
Prior art keywords: glucose; enzyme; reaction; determination; test system
Prior art date: 1982-03-26

Application number

CS831987A

Other languages

Czech (cs)

English (en)

Inventor

Berthold Limbach

Roland Helger

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-03-26

Filing date

1983-03-23

Publication date

1987-04-16

1983-03-23 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

1987-04-16 Publication of CS250227B2 publication Critical patent/CS250227B2/cs

Links

238000012360 testing method Methods 0.000 title claims description 33
239000000126 substance Substances 0.000 title claims description 19
239000007788 liquid Substances 0.000 title 1
102000004190 Enzymes Human genes 0.000 claims description 40
108090000790 Enzymes Proteins 0.000 claims description 40
229940088598 enzyme Drugs 0.000 claims description 40
238000006243 chemical reaction Methods 0.000 claims description 29
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 27
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 26
239000008103 glucose Substances 0.000 claims description 26
229950006238 nadide Drugs 0.000 claims description 26
108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 22
239000004366 Glucose oxidase Substances 0.000 claims description 10
108010015776 Glucose oxidase Proteins 0.000 claims description 10
229940116332 glucose oxidase Drugs 0.000 claims description 10
235000019420 glucose oxidase Nutrition 0.000 claims description 10
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 8
102000003992 Peroxidases Human genes 0.000 claims description 7
229910019142 PO4 Inorganic materials 0.000 claims description 5
239000000370 acceptor Substances 0.000 claims description 5
239000012530 fluid Substances 0.000 claims description 5
239000010452 phosphate Substances 0.000 claims description 5
125000003831 tetrazolyl group Chemical group 0.000 claims description 4
241000194107 Bacillus megaterium Species 0.000 claims description 3
108010046301 glucose peroxidase Proteins 0.000 claims description 3
108020005199 Dehydrogenases Proteins 0.000 claims description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
229930024421 Adenine Natural products 0.000 claims 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 1
229930006000 Sucrose Natural products 0.000 claims 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
229960000643 adenine Drugs 0.000 claims 1
ANNOWMBWHHKGLN-UHFFFAOYSA-N pyridine-3,5-dicarboxamide Chemical compound NC(=O)C1=CN=CC(C(N)=O)=C1 ANNOWMBWHHKGLN-UHFFFAOYSA-N 0.000 claims 1
239000005720 sucrose Substances 0.000 claims 1
FBWADIKARMIWNM-UHFFFAOYSA-N N-3,5-dichloro-4-hydroxyphenyl-1,4-benzoquinone imine Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1N=C1C=CC(=O)C=C1 FBWADIKARMIWNM-UHFFFAOYSA-N 0.000 description 12
238000005259 measurement Methods 0.000 description 11
239000005515 coenzyme Substances 0.000 description 10
230000008033 biological extinction Effects 0.000 description 8
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 7
102000003855 L-lactate dehydrogenase Human genes 0.000 description 6
108700023483 L-lactate dehydrogenases Proteins 0.000 description 6
238000000034 method Methods 0.000 description 6
239000011541 reaction mixture Substances 0.000 description 6
230000001419 dependent effect Effects 0.000 description 5
230000001575 pathological effect Effects 0.000 description 5
239000000758 substrate Substances 0.000 description 5
108010021809 Alcohol dehydrogenase Proteins 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
239000007795 chemical reaction product Substances 0.000 description 4
238000006911 enzymatic reaction Methods 0.000 description 4
239000008363 phosphate buffer Substances 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
239000000376 reactant Substances 0.000 description 3
230000000007 visual effect Effects 0.000 description 3
241000588624 Acinetobacter calcoaceticus Species 0.000 description 2
102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
101710088194 Dehydrogenase Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000003153 chemical reaction reagent Substances 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
238000011197 physicochemical method Methods 0.000 description 2
239000012898 sample dilution Substances 0.000 description 2
239000012488 sample solution Substances 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
JJMQRJKPLUACSO-UHFFFAOYSA-N 3-(4-iodophenyl)-2-(4-nitrophenyl)-5-phenyl-1,3-dihydrotetrazol-3-ium;chloride Chemical compound [Cl-].C1=CC([N+](=O)[O-])=CC=C1N1N(C=2C=CC(I)=CC=2)[NH2+]C(C=2C=CC=CC=2)=N1 JJMQRJKPLUACSO-UHFFFAOYSA-N 0.000 description 1
FFISWZPYNKWIRR-UHFFFAOYSA-N 5-oxidophenazin-5-ium Chemical compound C1=CC=C2[N+]([O-])=C(C=CC=C3)C3=NC2=C1 FFISWZPYNKWIRR-UHFFFAOYSA-N 0.000 description 1
102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
241000589291 Acinetobacter Species 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
102000057621 Glycerol kinases Human genes 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000005548 Hexokinase Human genes 0.000 description 1
108700040460 Hexokinases Proteins 0.000 description 1
208000008454 Hyperhidrosis Diseases 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
108700020962 Peroxidase Proteins 0.000 description 1
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
101710163410 Probable glycerol kinase Proteins 0.000 description 1
241000589774 Pseudomonas sp. Species 0.000 description 1
239000002250 absorbent Substances 0.000 description 1
230000002745 absorbent Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000001143 conditioned effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000007357 dehydrogenase reaction Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
208000013219 diaphoresis Diseases 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
238000007824 enzymatic assay Methods 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
229940020947 fluorescein sodium Drugs 0.000 description 1
AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
238000007654 immersion Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
229940049920 malate Drugs 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
239000000463 material Substances 0.000 description 1
CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
229960000907 methylthioninium chloride Drugs 0.000 description 1
235000001968 nicotinic acid Nutrition 0.000 description 1
239000011664 nicotinic acid Substances 0.000 description 1
229960003512 nicotinic acid Drugs 0.000 description 1
238000006395 oxidase reaction Methods 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
-1 phenazinethosulphate Chemical compound 0.000 description 1
239000000047 product Substances 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical class C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
230000027756 respiratory electron transport chain Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
238000010998 test method Methods 0.000 description 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/805—Test papers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Emergency Medicine (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

CS831987A 1982-03-26 1983-03-23 Testing system for substances' determination liquids CS250227B2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19823211167 DE3211167A1 (de)	1982-03-26	1982-03-26	Testsystem und verfahren zur bestimmung von substanzen in fluessigkeiten

Publications (1)

Publication Number	Publication Date
CS250227B2 true CS250227B2 (en)	1987-04-16

Family

ID=6159381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CS831987A CS250227B2 (en)	1982-03-26	1983-03-23	Testing system for substances' determination liquids

Country Status (8)

Country	Link
US (1)	US4490465A (xx)
EP (1)	EP0090223B1 (xx)
JP (1)	JPS58175498A (xx)
CS (1)	CS250227B2 (xx)
DD (1)	DD209478A5 (xx)
DE (2)	DE3211167A1 (xx)
IL (1)	IL68198A (xx)
ZA (1)	ZA832105B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3247894A1 (de) *	1982-12-24	1984-06-28	Merck Patent Gmbh, 6100 Darmstadt	Testsystem und verfahren zur bestimmung von nad(p)h
US4923800A (en) *	1984-01-10	1990-05-08	Ly Uy Vu	Instrumentless quantitative analysis system
US4654310A (en) *	1984-01-10	1987-03-31	Ly Uy Vu	Instrumentless quantitative analysis system
US4746607A (en) *	1985-02-07	1988-05-24	Eastman Kodak Company	Use of substituted quinone electron transfer agents in analytical determinations
US4649121A (en) *	1985-02-26	1987-03-10	Miles Laboratories, Inc.	Viability test device
US4772550A (en) *	1986-02-10	1988-09-20	Miles Inc.	Heterogeneous specific binding assay employing an aggregatable binding reagent
US4975367A (en) *	1986-04-04	1990-12-04	Miles Inc.	Catalytic test composition intended to produce a range of colors
CA1295216C (en) *	1986-04-04	1992-02-04	James P. Albarella	Rainbow test device
US4898813A (en) *	1986-04-04	1990-02-06	Albarella James P	Catalytic test composition intended to produce a range of colors
US5220035A (en) *	1986-04-04	1993-06-15	Miles Inc.	Dithiol-(2-nitrobenzoate) indicators
US4812400A (en) *	1986-07-14	1989-03-14	Steinman Gary D	Process for measuring sodium levels in biological fluids
US4814142A (en) *	1987-05-22	1989-03-21	Polymer Technology International Corp.	Test strip having a non-particulate dialyzed polymer layer
US5037738A (en) *	1987-06-03	1991-08-06	Abbott Laboratories	Simultaneous assay for glucose and urea
US4855228A (en) *	1987-09-11	1989-08-08	Miles Inc.	Multiple oxidative indicator system for visual determination of hydrogen peroxide
US5200325A (en) *	1988-02-10	1993-04-06	Miles Inc.	Self-indicating analysis employing stoichiometric chemical subtraction
JP2811319B2 (ja) *	1989-04-18	1998-10-15	旭化成工業株式会社	胆汁酸の高感度測定法および測定用組成物
US5334507A (en) *	1991-09-20	1994-08-02	Toyo Boseki Kabushiki Kaisha	Composition for measurement of potassium ion concentration and composition for elimination of ammonium ions
DE4215275A1 (de) *	1992-05-09	1993-11-11	Merck Patent Gmbh	Mittel und Verfahren zur Behandlung von Körperflüssigkeiten bei der Bestimmung von Neopterin
JPH06153991A (ja) *	1992-11-18	1994-06-03	Unitika Ltd	ホスファターゼ測定試薬
US5416004A (en) *	1993-01-19	1995-05-16	Detwiler; Richard L.	Multilayer analytical element containing primary amine buffer and method for the determination of ethanol
US20020010406A1 (en)	1996-05-17	2002-01-24	Douglas Joel S.	Methods and apparatus for expressing body fluid from an incision
US5824491A (en) *	1996-05-17	1998-10-20	Mercury Diagnostics, Inc.	Dry reagent test strip comprising benzidine dye precursor and antipyrine compound
EP1579814A3 (en)	1996-05-17	2006-06-14	Roche Diagnostics Operations, Inc.	Methods and apparatus for sampling and analyzing body fluid
ATE335435T1 (de)	2001-06-08	2006-09-15	Hoffmann La Roche	Entnahmevorrichtung für körperflüssigkeiten und testmedienskassette
WO2002100278A1 (en) *	2001-06-08	2002-12-19	Roche Diagnostics Gmbh	Sampling devices and methods utilizing a horizontal capillary test strip
US7731900B2 (en)	2002-11-26	2010-06-08	Roche Diagnostics Operations, Inc.	Body fluid testing device
US7244264B2 (en) *	2002-12-03	2007-07-17	Roche Diagnostics Operations, Inc.	Dual blade lancing test strip
US7582258B2 (en)	2002-12-23	2009-09-01	Roche Diagnostics Operations, Inc.	Body fluid testing device
ES2522972T3 (es)	2002-12-23	2014-11-19	F.Hoffmann-La Roche Ag	Dispositivo para ensayar fluidos corporales
US20040127818A1 (en)	2002-12-27	2004-07-01	Roe Steven N.	Precision depth control lancing tip
ATE445360T1 (de) *	2002-12-30	2009-10-15	Hoffmann La Roche	Blutaquisitionssuspensionssystem
EP1581114B1 (en) *	2002-12-30	2014-04-30	Roche Diagnostics GmbH	Flexible test strip lancet device
US7214200B2 (en) *	2002-12-30	2007-05-08	Roche Diagnostics Operations, Inc.	Integrated analytical test element
EP1589873B1 (en) *	2003-01-29	2011-12-21	Roche Diagnostics GmbH	Integrated lancing test strip
US7909776B2 (en)	2004-04-30	2011-03-22	Roche Diagnostics Operations, Inc.	Lancets for bodily fluid sampling supplied on a tape
US7322942B2 (en)	2004-05-07	2008-01-29	Roche Diagnostics Operations, Inc.	Integrated disposable for automatic or manual blood dosing
US7488298B2 (en)	2004-10-08	2009-02-10	Roche Diagnostics Operations, Inc.	Integrated lancing test strip with capillary transfer sheet
EP1870046A1 (de) *	2006-06-22	2007-12-26	Roche Diagnostics GmbH	Biegeweiche Vorrichtung zum Einbringen einer medizinischen Vorrichtung in den Körper
ATE534328T1 (de) *	2007-05-29	2011-12-15	Hoffmann La Roche	Flexible lanzette in einem lanzettensystem
WO2012028697A1 (en)	2010-09-01	2012-03-08	Eth Zürich, Institute Of Molecular Biology And Biophysics	Affinity purification system based on donor strand complementation
WO2014066670A1 (en)	2012-10-24	2014-05-01	Calysta Energy, Inc.	Engineering of multi-carbon substrate utilization pathways in methanotrophic bacteria
EP4108678A4 (en) *	2020-02-21	2024-03-27	Kikkoman Corporation	DEVICE FOR EVALUATION OF THE CONDITION OF A SAMPLE, SYSTEM COMPRISING SAME, METHOD FOR EVALUATION OF THE CONDITION OF A SAMPLE AND LACTATE DEHYDROGENASE USED FOR THIS PURPOSE
WO2022071417A1 (ja) *	2020-09-29	2022-04-07	キッコーマン株式会社	フラビン依存性乳酸デヒドロゲナーゼを含む組成物の安定性を向上する方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE142973C (xx) *
DE143180C (xx) *
SE173761C1 (xx) *	1956-11-07	1960-12-20
JPS4940192A (xx) *	1972-08-17	1974-04-15
CA1056746A (en) *	1974-09-06	1979-06-19	Chung J. Lai	Biologically active membrane material
US4056442A (en) *	1976-06-01	1977-11-01	The Dow Chemical Company	Lipase composition for glycerol ester determination
US4120755A (en) *	1977-04-28	1978-10-17	Beckman Instruments, Inc.	Kinetic method for determination of glucose concentrations with glucose dehydrogenase
SU905787A1 (ru) *	1978-07-31	1982-02-15	Иркутский Государственный Медицинский Институт	Способ определени аденозинтрифосфорной кислоты в крови
DE2905708A1 (de) *	1979-02-15	1980-08-28	Vitatron Scientific Bv	Verfahren zur photometrischen bestimmung von zwei oder mehr bestandteilen einer fluessigkeitsprobe sowie reagenzsatz zur durchfuehrung dieser photometrischen bestimmung
US4259440A (en) *	1979-05-21	1981-03-31	Miles Laboratories, Inc.	Hydrolysis and assay of triglycerides
SU857874A1 (ru) *	1979-07-23	1981-08-23	Ордена Ленина Институт Химической Физики Ан Ссср	Способ количественного определени глюкозы
DE2950381A1 (de) *	1979-12-14	1981-06-19	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren und reagens zur bestimmulng von triglyceriden
US4309502A (en) *	1980-06-30	1982-01-05	Beckman Instruments, Inc.	Enzymatic assay for glycerol and triglycerides and a reagent for use therein
US4340669A (en) *	1981-02-12	1982-07-20	Miles Laboratories, Inc.	System for the determination of glucose in fluids
DE3210095A1 (de) *	1982-03-19	1983-09-29	Boehringer Mannheim Gmbh, 6800 Mannheim	Verfahren und reagenz zur bestimmung von glycerin

1982
- 1982-03-26 DE DE19823211167 patent/DE3211167A1/de not_active Withdrawn
1983
- 1983-03-11 EP EP83102388A patent/EP0090223B1/de not_active Expired
- 1983-03-11 DE DE8383102388T patent/DE3373314D1/de not_active Expired
- 1983-03-22 IL IL68198A patent/IL68198A/xx unknown
- 1983-03-23 CS CS831987A patent/CS250227B2/cs unknown
- 1983-03-24 ZA ZA832105A patent/ZA832105B/xx unknown
- 1983-03-24 DD DD83249136A patent/DD209478A5/de not_active IP Right Cessation
- 1983-03-25 JP JP58049099A patent/JPS58175498A/ja active Pending
- 1983-03-25 US US06/478,765 patent/US4490465A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JPS58175498A (ja)	1983-10-14
EP0090223B1 (de)	1987-09-02
DD209478A5 (de)	1984-05-09
US4490465A (en)	1984-12-25
EP0090223A3 (en)	1985-08-14
IL68198A (en)	1986-09-30
DE3373314D1 (en)	1987-10-08
ZA832105B (en)	1983-12-28
EP0090223A2 (de)	1983-10-05
DE3211167A1 (de)	1983-09-29
IL68198A0 (en)	1983-06-15

Publication	Publication Date	Title
CS250227B2 (en)	1987-04-16	Testing system for substances' determination liquids
EP0240849B1 (en)	1993-11-24	Controlled hue test device
Akimoto et al.	1990	Luminol chemiluminescence reaction catalyzed by a microbial peroxidase
EP0823943B1 (en)	1999-07-28	Determination of glycated proteins
JPS61146196A (ja)	1986-07-03	Ｈ↓２ｏ↓２の測色的測定を改善するための方法び試薬
JPH0470000B2 (xx)	1992-11-09
EP0200540B1 (en)	1992-01-02	Analytical element and method for determination of creatine kinase isoenzyme
US4215197A (en)	1980-07-29	Test means and method for creatinine determination
CS244665B2 (en)	1986-08-14	Method of enzymatic determination of enzyme substrates
EP0116307B1 (en)	1988-01-07	Composition, analytical element and method for the quantification of creatine kinase
EP0133681B1 (en)	1988-09-14	Enzymatic urea assay
Kohlbecker et al.	1981	Direct spectrophotometric determination of serum and urinary oxalate with oxalate oxidase
US20020031794A1 (en)	2002-03-14	Method and reagent for quantitative determination of 1,5- anhydroglucitol
Majkić-Singh et al.	1987	Spectrophotometric assay of xanthine oxidase with 2, 2'-azino-di (3-ethylbenzthiazoline-6-sulphonate)(ABTS) as chromogen
Orfanos et al.	1984	A rapid screening test for Duchenne muscular dystrophy using dried blood specimens
EP0285998B1 (en)	1993-08-04	Method and reagent for determination of dehydrogenase or its substrate
Perlstein et al.	1978	Spectrophotometric study of bilirubin and hemoglobin interactions in several hydrogen peroxide generating procedures
Kayamori et al.	1997	Enzymatic method for assaying uric acid in serum with a new tetrazolium salt produces water-soluble formazan dye
JPS60210998A (ja)	1985-10-23	無機リン酸塩の酵素学的測定用試験組成物、試験具及び試験方法
JP3034984B2 (ja)	2000-04-17	Ｄ−ガラクトースの高感度定量法および定量用組成物
JPH0731498A (ja)	1995-02-03	１，５−アンヒドログルシトールの定量用キット及び該キットを使用する定量法
JPH0687798B2 (ja)	1994-11-09	体液中のカルシウム測定方法
JPH1118798A (ja)	1999-01-26	コレステロールの定量方法及び定量用試薬
US5487978A (en)	1996-01-30	Method, composition and device for the determination of cholesterol using cholesterol oxidase obtained from bacterial strain NRRL B-18713
JP2001116756A (ja)	2001-04-27	液状試薬および保存方法